- Home
- NFG vs JAZZ Comparison
NFG vs JAZZ Comparison
Compare NFG & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFG
- JAZZ
- Stock Information
- Founded
- NFG 1902
- JAZZ 2003
- Country
- NFG United States
- JAZZ Ireland
- Employees
- NFG N/A
- JAZZ N/A
- Industry
- NFG Oil/Gas Transmission
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- NFG Utilities
- JAZZ Health Care
- Exchange
- NFG Nasdaq
- JAZZ Nasdaq
- Market Cap
- NFG 7.5B
- JAZZ 7.7B
- IPO Year
- NFG N/A
- JAZZ 2007
- Fundamental
- Price
- NFG $86.56
- JAZZ $129.50
- Analyst Decision
- NFG Hold
- JAZZ Strong Buy
- Analyst Count
- NFG 5
- JAZZ 14
- Target Price
- NFG $90.40
- JAZZ $178.93
- AVG Volume (30 Days)
- NFG 520.9K
- JAZZ 745.7K
- Earning Date
- NFG 11-05-2025
- JAZZ 11-05-2025
- Dividend Yield
- NFG 2.47%
- JAZZ N/A
- EPS Growth
- NFG N/A
- JAZZ N/A
- EPS
- NFG 2.67
- JAZZ N/A
- Revenue
- NFG $2,183,330,000.00
- JAZZ $4,086,695,000.00
- Revenue This Year
- NFG $23.71
- JAZZ $5.65
- Revenue Next Year
- NFG $18.62
- JAZZ $5.79
- P/E Ratio
- NFG $32.41
- JAZZ N/A
- Revenue Growth
- NFG 12.45
- JAZZ 4.52
- 52 Week Low
- NFG $58.50
- JAZZ $95.49
- 52 Week High
- NFG $89.82
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- NFG 48.44
- JAZZ 67.67
- Support Level
- NFG $85.60
- JAZZ $127.52
- Resistance Level
- NFG $87.49
- JAZZ $133.00
- Average True Range (ATR)
- NFG 1.24
- JAZZ 2.90
- MACD
- NFG -0.12
- JAZZ 0.72
- Stochastic Oscillator
- NFG 49.21
- JAZZ 77.99
About NFG National Fuel Gas Company
National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.